<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">patmedfar</journal-id><journal-title-group><journal-title xml:lang="ru">Пациентоориентированная медицина и фармация</journal-title><trans-title-group xml:lang="en"><trans-title>Patient-Oriented Medicine and Pharmacy</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-1924</issn><publisher><publisher-name>LLC Izdatelstvo OKI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2949-1924-0136</article-id><article-id custom-type="edn" pub-id-type="custom">VJZOQW</article-id><article-id custom-type="elpub" pub-id-type="custom">patmedfar-231</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ХИМИЯ, ФАРМАКОГНОЗИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL CHEMISTRY, PHARMACOGNOSY</subject></subj-group></article-categories><title-group><article-title>Разработка и валидация методики определения 5‑фторурацила в составе полимерного комплекса на основе полиметакриловой кислоты методом УФ‑спектроскопии</article-title><trans-title-group xml:lang="en"><trans-title>Development and validation of a method for the determination of 5‑fluorouracil in a polymer complex based on polymethacrylic acid using UV spectroscopy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6454-1346</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жукова Ольга Вячеславовна — д. фарм. н., доцент, зав. кафедрой фармацевтической химии и фармакогнозии</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Olga V. Zhukova — Dr. Sci. (Pharm.), Associate Professor, Head of the Department of Pharmaceutical Chemistry and Pharmacognosy</p><p>Nizhniy Novgorod</p></bio><email xlink:type="simple">ov-zhukova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2110-5317</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дубовская</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dubovskaya</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дубовская Наталья Александровна — ассистент кафедры фармацевтической химии и фармакогнозии</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Natalya A. Dubovskaya — Assistant Professor, Department of Pharmaceutical Chemistry and Pharmacognosy</p><p>Nizhniy Novgorod</p></bio><email xlink:type="simple">nata.dubovskaya.99@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0032-0341</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлов</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlov</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хохлов Александр Леонидович — д. м. н., профессор, академик РАН, зав. кафедрой фармакологии и клинической фармакологии, ректор ФГБОУ ВО «Ярославский государственный медицинский университет», Председатель Совета по этике при Министерстве здравоохранения РФ</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Aleksandr L. Khokhlov — Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Head of the Department of Pharmacology and Clinical Pharmacology, Rector of the Yaroslavl State Medical University, Chairman of the Ethics Council under the Ministry of Health of the Russian Federation</p><p>Yaroslavl</p></bio><email xlink:type="simple">rector@ysmu.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ярославский государственный медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2026</year></pub-date><volume>4</volume><issue>2</issue><fpage>5</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жукова О.В., Дубовская Н.А., Хохлов А.Л., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Жукова О.В., Дубовская Н.А., Хохлов А.Л.</copyright-holder><copyright-holder xml:lang="en">Zhukova O.V., Dubovskaya N.A., Khokhlov A.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pomph.ru/jour/article/view/231">https://www.pomph.ru/jour/article/view/231</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. 5-фторурацил (5-ФУ) является базовым химиотерапевтическим агентом, однако его клиническое применение ограничено быстрым метаболизмом и высокой токсичностью. Разработка систем контролируемого высвобождения на основе полиметакриловой кислоты (ПМАК) позволяет улучшить фармакокинетический профиль препарата, что требует валидации методик анализа полученного соединения для обеспечения требований качества таких полимерных систем.</p></sec><sec><title>Цель</title><p>Цель. Разработка и валидация методики количественного определения 5-ФУ в полимерном комплексе на основе ПМАК методом УФ-спектроскопии в различных средах, имитирующих биологические условия.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Объектом исследования служил лиофилизированный полимерный комплекс 5-ФУ и ПМАК, полученный методом жидкофазного синтеза. Анализ проводился методом УФ-спектроскопии на приборе Shimadzu UV-1800 при длине волны 265–267 нм. Методика валидирована в соответствии с ГФ XV по показателям: специфичность, линейность, правильность, повторяемость и внутрилабораторная прецизионность (с участием двух операторов). Исследования велись в трёх средах: очищенная вода, фосфатный буфер (pH 7,4 кровь) и цитратный буфер (pH 5,1 внутриклеточная среда).</p></sec><sec><title>Результаты</title><p>Результаты. Подтверждено образование комплекса за счет водородных связей между 5-ФУ и карбоксильными группами ПМАК. Методика признана специфичной, так как полимерный носитель не поглощает в аналитической области (265 нм). Установлена линейная зависимость (R[<xref ref-type="bibr" rid="cit2">2</xref>] &gt; 0,999). Показатель открываемости (правильность) составил от 98,48 % для среды цитратного буферного раствора до 99,23 % для фосфатного буферного раствора. Коэффициент вариации (RSD) при проверке прецизионности не превысил 2 %, что подтверждает, что предложенный метод обладает удовлетворительной повторяемостью (сходимостью) и обеспечивает получение воспроизводимых результатов при многократном анализе проб в идентичных условиях. Расчётные критерии Стьюдента и Фишера подтвердили отсутствие систематических ошибок между операторами. В результате исследования выявлено, что в кислой среде (pH 5,1) высвобождение 5-ФУ на 15,92 % выше, чем при pH 7,4, что подтверждает pH-чувствительность системы.</p></sec><sec><title>Выводы</title><p>Выводы. Разработанная спектрофотометрическая методика полностью отвечает требованиям валидности и может быть использована для контроля качества полимерных систем доставки 5-ФУ на основе ПМАК. Выявленная избирательность высвобождения 5-ФУ в кислой среде подтверждает перспективность использования полимерных комплексов для направленной доставки в опухолевые ткани.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. 5-fluorouracil (5-FU) is a basic chemotherapeutic agent, but its clinical use is limited by rapid metabolism and high toxicity. The development of controlled release systems based on polymethacrylic acid (PMAA) allows for an improved pharmacokinetic profile of the drug, which requires validation of analytical methods for the resulting compound to ensure the quality requirements of such polymer systems.</p></sec><sec><title>Objective</title><p>Objective. Development and validation of a method for the quantitative determination of 5-FU in a PMAA based polymer complex using UV spectroscopy in various media simulating biological conditions.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The object of the study was a lyophilized polymer complex of 5-FU and PMAA, obtained by liquid phase synthesis. The analysis was performed by UV spectroscopy on a Shimadzu UV-1800 instrument at a wavelength of 265–267 nm. The method was validated in accordance with the State Pharmacopoeia XV for the following parameters: specificity, linearity, accuracy, repeatability, and intralaboratory precision (with the participation of two operators). The studies were conducted in three media: purified water, phosphate buffer (pH 7.4 blood) and citrate buffer (pH 5.1 intracellular medium).</p></sec><sec><title>Results</title><p>Results. Complex formation via hydrogen bonds between 5-FU and the carboxyl groups of PMAA was confirmed. The method was deemed specific, as the polymer carrier does not absorb in the analytical range (265 nm). A linear relationship was established (R[<xref ref-type="bibr" rid="cit2">2</xref>] &gt; 0.999). The recovery rate (accuracy) ranged from 98.48 % for a citrate buffer solution to 99.23 % for a phosphate buffer solution. The coefficient of variation (RSD) during precision testing did not exceed 2 %, confirming that the proposed method has satisfactory repeatability (convergence) and ensures reproducible results with multiple sample analyses under identical conditions. Calculated Student's and Fisher's t-tests confirmed the absence of systematic errors between operators. The study revealed that in an acidic environment (pH 5.1), the release of 5-FU was 15.92 % higher than at pH 7.4, confirming the pH sensitivity of the system.</p></sec><sec><title>Conclusions</title><p>Conclusions. The developed spectrophotometric method fully meets validity requirements and can be used for quality control of PMAA based polymeric 5-FU delivery systems. The demonstrated selectivity of 5-FU release in an acidic environment confirms the potential of using polymeric complexes for targeted delivery to tumor tissue.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>5-фторурацил</kwd><kwd>полиметакриловая кислота</kwd><kwd>полимерный комплекс 5-фторурацила на основе полиметакриловой кислоты</kwd><kwd>УФ-спектроскопия</kwd><kwd>валидация методики количественного определения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>5-fluorouracil</kwd><kwd>polymethacrylic acid</kwd><kwd>polymeric complex of 5-fluorouracil based on polymethacrylic acid</kwd><kwd>UV-spectroscopy</kwd><kwd>validation of the quantitative determination method</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989 Apr;16(4): 215-37. doi: 10.2165/00003088-198916040-00002</mixed-citation><mixed-citation xml:lang="en">Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989 Apr;16(4): 215-37. doi: 10.2165/00003088-198916040-00002</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kennedy BJ. 5-fluorouracil toxicity: old or new? Cancer. 1999 Oct 1;86(7):1099-100.</mixed-citation><mixed-citation xml:lang="en">Kennedy BJ. 5-fluorouracil toxicity: old or new? Cancer. 1999 Oct 1;86(7):1099-100.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Alter P, Herzum M, Soufi M, et al. Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5. doi: 10.2174/187152506775268785.</mixed-citation><mixed-citation xml:lang="en">Alter P, Herzum M, Soufi M, et al. Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5. doi: 10.2174/187152506775268785.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Naren G, Guo J, Bai Q, et al. Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans. Expert Rev Mol Med. 2022 Jan 31;24:e9. doi: 10.1017/erm.2022.3.</mixed-citation><mixed-citation xml:lang="en">Naren G, Guo J, Bai Q, et al. Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans. Expert Rev Mol Med. 2022 Jan 31;24:e9. doi: 10.1017/erm.2022.3.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Szota M, Reczyńska-Kolman K, Pamuła E, et al. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies. Int J Mol Sci. 2021 Oct 16;22(20):11167. doi: 10.3390/ijms222011167.</mixed-citation><mixed-citation xml:lang="en">Szota M, Reczyńska-Kolman K, Pamuła E, et al. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies. Int J Mol Sci. 2021 Oct 16;22(20):11167. doi: 10.3390/ijms222011167.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W, Joyce P, Bremmell K, et al. Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis. Pharmaceutics. 2022 Jan 18;14(2):221. doi: 10.3390/pharmaceutics14020221.</mixed-citation><mixed-citation xml:lang="en">Wang W, Joyce P, Bremmell K, et al. Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis. Pharmaceutics. 2022 Jan 18;14(2):221. doi: 10.3390/pharmaceutics14020221.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mashaqbeh H, Obaidat R, Al-Shar'i NA, et al. Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin: in vitro and in silico studies. Res Pharm Sci. 2022 Jul 14;17(4):334-349. doi: 10.4103/1735-5362.350235.</mixed-citation><mixed-citation xml:lang="en">Mashaqbeh H, Obaidat R, Al-Shar'i NA, et al. Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin: in vitro and in silico studies. Res Pharm Sci. 2022 Jul 14;17(4):334-349. doi: 10.4103/1735-5362.350235.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Szota M, Wolski P, Carucci C, et al. Effect of Ionization Degree of Poly(amidoamine) Dendrimer and 5-Fluorouracil on the Efficiency of Complex Formation-A Theoretical and Experimental Approach. Int J Mol Sci. 2023 Jan 3;24(1):819. doi: 10.3390/ijms24010819.</mixed-citation><mixed-citation xml:lang="en">Szota M, Wolski P, Carucci C, et al. Effect of Ionization Degree of Poly(amidoamine) Dendrimer and 5-Fluorouracil on the Efficiency of Complex Formation-A Theoretical and Experimental Approach. Int J Mol Sci. 2023 Jan 3;24(1):819. doi: 10.3390/ijms24010819.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grant JJ, Pillai SC, Perova TS, et al. Enhancement of 5-Fluorouracil Drug Delivery in a Graphene Oxide Containing Electrospun Chitosan/Polyvinylpyrrolidone Construct. Materials (Basel). 2024 Oct 31;17(21):5300. doi: 10.3390/ma17215300/</mixed-citation><mixed-citation xml:lang="en">Grant JJ, Pillai SC, Perova TS, et al. Enhancement of 5-Fluorouracil Drug Delivery in a Graphene Oxide Containing Electrospun Chitosan/Polyvinylpyrrolidone Construct. Materials (Basel). 2024 Oct 31;17(21):5300. doi: 10.3390/ma17215300/</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tang H, Guo J, Sun Y, et al. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm 2011;421:388-96.</mixed-citation><mixed-citation xml:lang="en">Tang H, Guo J, Sun Y, et al. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm 2011;421:388-96.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yilmaz G, Demir B, Timur S, Becer CR. Poly (methacrylic acid)- coated gold nanoparticles: functional platforms for theranostic applications. Biomacromolecules 2016;17:2901-11.</mixed-citation><mixed-citation xml:lang="en">Yilmaz G, Demir B, Timur S, Becer CR. Poly (methacrylic acid)- coated gold nanoparticles: functional platforms for theranostic applications. Biomacromolecules 2016;17:2901-11.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhukova OV, Dubovskaya NA, Zykova DA, et al. Specifics of Pharmacokinetics and Biodistribution of 5-Fluorouracil Polymeric Complex. Molecules. 2023 Dec 15;28(24):8096. doi: 10.3390/molecules28248096.</mixed-citation><mixed-citation xml:lang="en">Zhukova OV, Dubovskaya NA, Zykova DA, et al. Specifics of Pharmacokinetics and Biodistribution of 5-Fluorouracil Polymeric Complex. Molecules. 2023 Dec 15;28(24):8096. doi: 10.3390/molecules28248096.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Razavi L, Raissi H, Farzad F. Validation of an MD simulation approach for electrical field responsive micelles and their application in drug delivery. Sci Rep. 2023 Feb 15;13(1):2665. doi: 10.1038/s41598-023-29835-y.</mixed-citation><mixed-citation xml:lang="en">Razavi L, Raissi H, Farzad F. Validation of an MD simulation approach for electrical field responsive micelles and their application in drug delivery. Sci Rep. 2023 Feb 15;13(1):2665. doi: 10.1038/s41598-023-29835-y.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Galbis E, Iglesias N, Lucas R, Tinajero-Díaz E, de-Paz MV, Muñoz-Guerra S, Galbis JA. Validation of Smart Nanoparticles as Controlled Drug Delivery Systems: Loading and pH-Dependent Release of Pilocarpine. ACS Omega. 2018 Jan 31;3(1):375-382. doi: 10.1021/acsomega.7b01421.</mixed-citation><mixed-citation xml:lang="en">Galbis E, Iglesias N, Lucas R, Tinajero-Díaz E, de-Paz MV, Muñoz-Guerra S, Galbis JA. Validation of Smart Nanoparticles as Controlled Drug Delivery Systems: Loading and pH-Dependent Release of Pilocarpine. ACS Omega. 2018 Jan 31;3(1):375-382. doi: 10.1021/acsomega.7b01421.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Дубовская Н.А., Жукова О.В. Получение и оценка комплекса полимера метакриловой кислоты и 5-фторурацила при различных условиях рH среды. Современные проблемы естественных наук и фармации. Сборник статей Всероссийской научной конференции; 20–23 мая 2025 г.; Марийский гос. ун-т., Йошкар-Ола; 2025;(14):332-335.</mixed-citation><mixed-citation xml:lang="en">Dubovskaya N.A., Zhukova O.V. Preparation and evaluation of a complex of methacrylic acid polymer and 5-fluorouracil under different pH conditions. Modern problems of natural sciences and pharmacy. Collection of articles of the All-Russian scientific conference; May 20–23, 2025; Mari State University, Yoshkar-Ola; 2025; (14): 332–335.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Государственная фармакопея Российской Федерации. XV издание. — Москва, 2023. — URL: https://pharmacopoeia.regmed.ru/pharmacopoeia/izdanie-15 (дата обращения: 05.02.2026). — Текст: электронный.</mixed-citation><mixed-citation xml:lang="en">State Pharmacopoeia of the Russian Federation. 15th edition. Moscow, 2023.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
